Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no cost. Institution and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and securely-locked area as per Protocol requirements; (iii) will use Study Drug only for Study purposes and according to the Protocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the Study Drug or any portion thereof to any third party without first obtaining written approval from Idorsia. 1.7.1 Xxxxxx a užívání. Společnost Idorsia vlastní Hodnocený přípravek nebo má k němu všechna nezbytná práva. Společnost Idorsia nebo její spřízněná společnost poskytne Zdravotnickému zařízení Hodnocený přípravek bezplatně. Zdravotnické zařízení a Zkoušející: (i) potvrdí společnosti Idorsia převzetí Hodnoceného přípravku; (ii) uchovávají Hodnocený přípravek na bezpečném a bezpečně uzamčeném místě v souladu s požadavky Protokolu; (iii) užívají Hodnocený přípravek výhradně pro účely provádění Klinického hodnocení a v souladu s Protokolem; (iv) omezí přístup k Hodnocenému přípravku pouze na ty Pracovníky podílející se na klinickém hodnocení, kteří jsou pod přímou kontrolou Zkoušejícího; (v) nevydávají Subjektům exspirované Hodnocený přípravek; a (vi) bez předchozího písemného souhlasu společnosti Idorsia nepředávají žádné třetí osobě Hodnocený přípravek ani žádnou jeho část. Pharmacy Services: Institution shall ensure that its Pharmacy (the “Pharmacy”) performs services required by the Institution and/or Investigator in compliance with the Protocol (the “Pharmacy Services”). The Pharmacy Services shall include: drug receipt and dispension. Služby lékárny: Zdravotnické zařízení zajistí, aby nemocniční lékárna (“Lékárna”) poskytovala služby požadované Zdravotnickým zařízením a/nebo Zkoušejícím v souladu s Protokolem (“Služby lékárny”). Služby Lékárny zahrnují: příjem a výdej léčiva.
Supply and Use. Actelion owns or has the necessary rights to the Study Drug. Actelion or its corporate affiliate will provide the Study Drug to Institution at no cost. Institution and Investigator; (i) will verify to Actelion receipt of the Study Drug; (ii) will store the Study Drug in a safe and securely- locked area per Protocol requirements; (iii) will use Study Drug only for Study purposes and according to the Protocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the Study Drug or any portion thereof to any third party without first obtaining written approval from Actelion. 1.7.2
Supply and Use. The Provider shall supply the Material and the Provider Know-how to the Recipient at the premises of the Recipient. Risk in the Material [and the Provider Know-how] shall pass to the Recipient on delivery. The Recipient shall: only use the Material, Provider IPR and Provider Know-how for the Purpose during the Term in compliance with good laboratory practice, the highest standards of skill and care and all applicable laws and regulations [and the Provider's instructions concerning storage and use of the Materials]; ensure that the personnel handling the Material are apprised of any known hazards and warrants that they are qualified by training and experience to perform the Purpose; the Material is not for use in humans, in clinical trials, or for diagnostic purposes involving human subjects without the written consent of the Provider; the Recipient will not use any of the Materials for any commercial purpose or commercially-sponsored research without the prior written consent of the Provider which consent may be granted at the Provider’s sole discretion; and the Material is not to be given or made available to any third party or person, except Recipient’s employees, consultants, contract research organizations or collaborators that are bound by terms and conditions similar to the terms and conditions that are contained herein and shall not be used for any purpose other than for the Purpose. All requests for the Material from a third party other than Recipient’s employees, consultants, contract research organizations or collaborators will be referred to the Provider.
Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no cost. Institution and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and securely-locked area as per Protocol requirements; (iii) will use Study Drug only for Study purposes and according to the Protocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the Study Drug or any portion thereof to any third party without first obtaining written approval from Idorsia. 1.7
Supply and Use. Actelion owns or has the necessary rights to the Study Drug. Actelion or its corporate affiliate will provide the Study Drug to Institution at no cost. Institution and Investigator; (i) will verify to Actelion receipt of the Study Drug; (ii) will store the Study Drug in a safe and securely- locked area per Protocol requirements; (iii) will use Study Drug only for Study purposes
Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia will provide the Study Drug, placebo to Institution at no cost. Institution and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study 1.7
Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no cost. Institu- tion and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and se- curely-locked area as per Protocol require- ments; (iii) will use Study Drug only for Study purposes and according to the Pro- tocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the 1.7 Hodnocený přípravek. 1.7.1
Supply and Use
